Companies & Industry »Company News»Company News Details
Company News Details

BSE   25 Apr 18 | 12:00 AM

812.40 -6.7 (-0.82%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 500257
Face Value: N.A.

NSE   25 Apr 18 | 12:00 AM

814.70 -5.05 (-0.62%)
Mkt Price (Rs)   Chg Rs (Chg %)
1 Week : Rs 790.55 (2.76%)
1 Month : Rs 735.75 (10.42%)
1 Year : Rs 1,376.70 (-40.99%)
change companytradenow

Pharma major Lupin launches pain relief drug in US

Press Trust of India / New Delhi 09 Mar 17 | 12:35 PM

Drug firm Lupin announced the launch of pain relief drug Hydrocodone Bitartrate and Acetaminophen in the US market.

In a BSE filing, Lupin announced "the launch of Hydrocodone Bitartrate and Acetaminophen tablets USP, in the strengths of 5 mg/300 mg, 7.5 mg/300 mg and 10 mg/300 mg having received an approval from the United States Food and Drug Administration (USFDA) earlier."

Widgets Magazine

In November last year, Lupin said it had received final approval from the US health regulator for its Hydrocodone Bitartrate and Acetaminophen tablets used for providing pain relief.

The company's product is a generic equivalent of Mikart Inc's Hydrocodone Bitartrate and Acetaminophen tablets.

According to IMS MAT sales data, product had sales of $79.6 million in the US market.

Shares of Lupin were trading 0.48 per cent higher at Rs 1,454.80 on the BSE.

Widgets Magazine


Company Price Gain (%)
Bharti Airtel419.803.37
M & M854.251.88
Power Grid Corpn207.200.58


Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine